1,100 results on '"Agostinelli, Claudio"'
Search Results
102. Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome?
103. Ordering Curves by Data Depth
104. Robustness, Dispersion, and Local Functions in Data Depth
105. Bone Marrow in Hodgkin Lymphoma and Mimickers
106. Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified
107. Finite Mixtures of Multivariate Wrapped Normal Distributions for Model Based Clustering of p-Torus Data
108. The role of peritumoral CD8 + /TIA1 + lymphocytes in hepatocellular carcinoma aggressiveness and recurrence after surgical resection
109. NR1H3 (LXRα) is associated with pro‐inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b‐cell lymphoma
110. PD-1 and PD-L1 expression in mycosis fungoides and Sézary Syndrome
111. A novel immunohistochemical classifier to distinguish Hodgkin lymphoma from ALK anaplastic large cell lymphoma
112. Robust Model Selection with LARS Based on S-estimators
113. Fading With Time of PD-L1 Immunoreactivity in Non–Small Cells Lung Cancer Tissues: A Methodological Study
114. A large mass and erythematous‐violaceous plaques
115. Ein großer Tumor und livid‐erythematöse Plaques
116. Robust Estimators of the Generalized Log-Gamma Distribution
117. Aberrant expression of CD10 and BCL6 in mantle cell lymphoma
118. Finite Mixtures of Multivariate Wrapped Normal Distributions for Model Based Clustering of p-Torus Data.
119. A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report
120. Phylogenetic convolutional neural networks in metagenomics
121. Hierarchical Clustering by Means of Model Grouping
122. Analysis of macroseismic fields using statistical data depth functions: considerations leading to attenuation probabilistic modelling
123. Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of “germinotropic” lymphoproliferative disorder
124. TOX Expression in Mycosis Fungoides and Sezary Syndrome
125. Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation
126. Diffuse large B-cell lymphoma
127. Cytotoxic Epstein-Barr virus-positive large B cell lymphoma: a regulatory B cell-derived neoplasia?
128. CD38, BCL‐2, PD‐1, and PD‐1L expression in nodal peripheral T‐cell lymphoma: Possible biomarkers for novel targeted therapies?
129. BCL10 down-regulation in peripheral T-cell lymphomas
130. Rejoinder on: Robust estimation of multivariate location and scatter in the presence of cellwise and casewise contamination
131. Robust estimation of multivariate location and scatter in the presence of cellwise and casewise contamination
132. Cross calibration between XRF and ICP-MS for high spatial resolution analysis of ombrotrophic peat cores for palaeoclimatic studies
133. T-Cell Receptor Dependent and Independent NF-kappa B Activation is a Prognostic Marker and a Therapeutic Target in Peripheral T-cell Lymphoma Not Otherwise Specified
134. A three-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma
135. The role of myeloid derived suppressor cells in mycosis fungoides
136. Bounds for the Bias of Estimators Under Contamination
137. Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes
138. Local depth
139. Three-dimensional models: a novel approach for lymphoma research
140. Prognostic significance of Bcl-2 expression in primary cutaneous B-cell lymphoma: a reappraisal
141. Cutaneous composite lymphoma consisting of chronic lymphocytic leukemia/small lymphocytic lymphoma and follicular lymphoma: a unique entity and a putative pathological mechanism for cutaneous composite lymphomas
142. Cover Image
143. Progression in Ph-Chromosome-Negative Myeloproliferative Neoplasms: An Overview on Pathologic Issues and Molecular Determinants
144. The Microenvironment’s Role in Mycosis Fungoides and Sézary Syndrome: From Progression to Therapeutic Implications
145. Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia
146. Hodgkin Lymphoma: A Special Microenvironment
147. robustsur: Robust Estimation for Seemingly Unrelated Regression Models
148. Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network
149. TEST OF HYPOTHESES BASED ON THE WEIGHTED LIKELIHOOD METHODOLOGY
150. BRAFV600E mutations are found in Richter syndrome and may allow targeted therapy in a subset of patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.